Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

73 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   2011-2012 seasonal flu vaccine   -   -   -   -   [2]
3,
113 
 2   4-aminopyridine   Dalfampridine   D04127   [2] KCNA4, KCND2   [3] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   [2]
3,
13 
 3   4-cholesten-3-one, oxime   -   -   -   -   [2]
2,
3 
 4   4-cholesten-3-one,oxime   -   -   -   -   [1]
3 
 5   Adipose derived mesenchymal stem cell   -   -   -   -   [1]
3 
 6   Amifampridine   Amifampridine   D10228   [2] KCNA4, KCND2   [3] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   [3]
3,
11,
12 
 7   Amifampridine phosphate   Amifampridine   D10228   [2] KCNA4, KCND2   [3] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   [3]
3,
11,
12 
 8   Amifampridine phosphate 10 mg oral tablet   Amifampridine   D10228   [2] KCNA4, KCND2   [3] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   [1]
3 
 9   Avxs-101   -   -   -   -   [1]
3 
 10   Avxs-101 (previously known as scaav9.cb.smn)   -   -   -   -   [1]
3 
 11   Biocarn   -   -   -   -   [1]
3 
 12   Branaplam   Branaplam   -   -   -   [1]
3 
 13   Celecoxib   Celecoxib   D00567   [1] PTGS2   [20] Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   [8]
2,
3,
34,
46,
70,
89,
161,
271 
 14   Ck-2127107   Reldesemtiv   D11363   [1] TNNC2   [1] Calcium signaling pathway   [2]
2,
3 
 15   Ck-2127107 150 mg   Reldesemtiv   D11363   [1] TNNC2   [1] Calcium signaling pathway   [1]
3 
 16   Ck-2127107 450 mg   Reldesemtiv   D11363   [1] TNNC2   [1] Calcium signaling pathway   [1]
3 
 17   Human anti-promyostatin monoclonal antibody   -   -   -   -   [1]
3 
 18   Hydroxyurea   Hydroxyurea   D00341   [1] RRM2   [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   [8]
3,
13,
19,
20,
65,
85,
86,
284 
 19   Isis 396443   -   -   -   -   [1]
3 
 20   Isis 396443 (biib058)   -   -   -   -   [1]
3 
 21   Itraconazole   Itraconazole   D00350   -   -   [4]
3,
65,
227,
299 
 22   Leuprolide   Leuprolide   D00989, D08113   [1] GNRHR   [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction   [5]
1,
2,
3,
51,
76 
 23   Levocarnitine   Levocarnitine   D02030, D02176, D04713   -   -   [3]
3,
53,
97 
 24   Lmi070   -   -   -   -   [1]
3 
 25   Mestinon   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [3]
3,
6,
11 
 26   Midazolam   Midazolam   D00550, D00696, D05028   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [10]
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 27   N.a.   -   -   -   -   [8]
3,
6,
8,
13,
46,
97,
240,
256 
 28   Nerve growth factor   Nerve growth factor   -   -   -   [2]
3,
90 
 29   Norditropin simplexx   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [4]
3,
78,
193,
195 
 30   Norditropin simplexx 15 mg/1.5 ml   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
3 
 31   Nusinersen   Nusinersen   D10881   [1] SMN2   [1] RNA transport   [1]
3 
 32   Olesoxime   -   -   -   -   [2]
2,
3 
 33   Onasemnogene abeparvovec   -   -   -   -   [1]
3 
 34   Onasemnogene abeparvovec-xioi   -   -   -   -   [1]
3 
 35   Orfiril saft   -   -   -   -   [1]
3 
 36   Paracetamol   Acetaminophen   D00217   [2] PTGS1, PTGS2   [21] Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   [5]
3,
6,
13,
35,
46 
 37   Paracetamol 120mg/5ml oral suspension   Acetaminophen   D00217   [2] PTGS1, PTGS2   [21] Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   [1]
3 
 38   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   [10]
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 39   Phosphate   Phosphate ion   -   -   -   [29]
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 40   Placebo   -   -   -   -   [20]
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 41   Pyridostigmine   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [4]
3,
6,
11,
256 
 42   Pyridostigmine bromide   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [3]
3,
6,
256 
 43   Riluzole   Riluzole   D00775   [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   [7]
2,
3,
5,
8,
13,
17,
206 
 44   Risdiplam   Risdiplam   D11406   [1] SMN2   [1] RNA transport   [1]
3 
 45   Ro6885247/f03   -   -   -   -   [1]
3 
 46   Ro7034067   -   -   -   -   [1]
3 
 47   Ro7034067 / f12   -   -   -   -   [1]
3 
 48   Ro7034067 / f13   -   -   -   -   [1]
3 
 49   Ro7034067/f06 with solvent (ro7034067/f08)   -   -   -   -   [1]
3 
 50   Ro7034067/f07 with solvent (ro7034067/f09)   -   -   -   -   [1]
3 
 51   Ro7034067/f12   -   -   -   -   [1]
3 
 52   Ro7034067/f13   -   -   -   -   [1]
3 
 53   Ro7090919   -   -   -   -   [1]
3 
 54   Rvg 03820   -   -   -   -   [1]
3 
 55   Salbutamol   Salbutamol   D02147   [1] ADRB2   [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   [8]
3,
11,
49,
85,
86,
228,
256,
299 
 56   Sesame oil   Sesame oil   D03314   -   -   [1]
3 
 57   Sesame oil, refined   Sesame oil   D03314   -   -   [1]
3 
 58   Smart   -   -   -   -   [1]
3 
 59   Sodium phenylbutyrate   Phenylbutyric acid   D05868   -   -   [4]
2,
3,
8,
251 
 60   Sodium phenylbutyrate (napb)   Phenylbutyric acid   D05868   -   -   [1]
3 
 61   Somatropin   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [15]
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 62   Spinraza   Nusinersen   D10881   [1] SMN2   [1] RNA transport   [1]
3 
 63   Srk-015   -   -   -   -   [1]
3 
 64   Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide   -   -   -   -   [1]
3 
 65   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   [1] AR   [3] Oocyte meiosis, Pathways in cancer, Prostate cancer   [7]
1,
2,
3,
13,
78,
113,
265 
 66   Tro19622   Tro19622   -   -   -   [3]
2,
3,
13 
 67   Valproate   Valproic acid   D00399   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [6]
2,
3,
90,
102,
233,
256 
 68   Valproate sodium   Valproic acid   D00399   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
3 
 69   Valproate, levocarnitine   Levocarnitine   D02030, D02176, D04713   -   -   [1]
3 
 70   Valproic acid   Valproic acid   D00399   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [10]
3,
5,
26,
34,
65,
89,
90,
222,
256,
331 
 71   Valproic acid (vpa)   Valproic acid   D00399   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
3 
 72   Valproic acid and levocarnitine   Levocarnitine, Valproic acid   D00399, D02030, D02176, D04713   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
3 
 73   Volmax*30cpr 4mg r.p.   -   -   -   -   [1]
3 

Back to top